C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

S. Haessler, A. Paez, M. Rothberg, T. Higgins

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients M. Giannella, M. Alonso,

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain A. Doménech-Sánchez Clinical Microbiology.

Candida glabrata fungaemia in intensive care units

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G

J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Non-antibiotic strategies for sepsis

Surveillance of Legionnaires’ disease in Austria

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A

Human infection with H9N2 avian influenza in northern China

Elements of design: the knowledge on which we build

J. S. Oxford, S. Bossuyt, S. Balasingam, A. Mann, P. Novelli, R

S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Seasonal H1N influenza virus infection is associated with elevated pre‐exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus M.

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona S. Borrell, G. Tudó, E. Rey, J. González-Martín

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

Influenza A(H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter Epidemiological Task Group for Overseas.

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Leishmaniasis in immunosuppressed individuals

Real-time comparative monitoring of the A/H1N1 pandemic in France

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Dynamics of clinical symptoms in patients with pandemic influenza A (H1N1) C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection Volume 16, Issue 4, Pages 389-390 (April 2010) DOI: 10.1111/j.1469-0691.2010.03117.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 The duration of clinical symptoms in patients infected with 2009 pandemic influenza A (H1N1). The bold vertical lines mean median duration of clinical symptoms. Clinical Microbiology and Infection 2010 16, 389-390DOI: (10.1111/j.1469-0691.2010.03117.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 The dynamics of clinical symptoms in patients infected with 2009 pandemic influenza A (H1N1). Clinical Microbiology and Infection 2010 16, 389-390DOI: (10.1111/j.1469-0691.2010.03117.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions